MiNK Therapeutics, Inc. (INKT)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20264 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to MiNK Therapeutics, Inc.’s names, not what it holds today.
4 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 19, 2025 | 12,391,741 | T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof | Biotechnology | MiNK Therapeutics, Inc. |
| Feb 13, 2024 | 11,898,165 | Engineered host cells and methods of use thereof | Biotechnology | MiNK Therapeutics, Inc. |
| Aug 8, 2023 | 11,718,658 | T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof | Biotechnology | MiNK Therapeutics, Inc. |
| Mar 28, 2023 | 11,613,764 | T cell receptors that bind to NY-ESO-1 and methods of use thereof | Biotechnology | MiNK Therapeutics, Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Nov 6, 2025 | 2025/0339529 | B-CELL MATURATION ANTIGEN (BCMA) CHIMERIC ANTIGEN RECEPTOR INVARIANT NATURAL KILLER T CELLS AND USES THEREOF | Medical technology | MiNK Therapeutics, Inc. |
| Nov 6, 2025 | 2025/0339468 | INVARIANT NATURAL KILLER T CELLS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | Pharmaceuticals | MiNK Therapeutics, Inc. |
| Sep 12, 2024 | 2024/0301025 | T CELL RECEPTORS THAT BIND TO MIXED LINEAGE LEUKEMIA (MLL)-SPECIFIC PHOSPHOPEPTIDES AND METHODS OF USE THEREOF | Biotechnology | MiNK Therapeutics, Inc. · patent 12,391,741 granted from it |
| Mar 28, 2024 | 2024/0102044 | T CELL RECEPTORS THAT BIND TO NY-ESO-1 AND METHODS OF USE THEREOF | Biotechnology | MiNK Therapeutics, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.